How should elevated ferritin with otherwise normal liver enzymes be evaluated?

Elevated Ferritin with Normal Liver Enzymes: Evaluation Approach

When ferritin is elevated but liver enzymes (ALT/AST) are normal, you must first measure transferrin saturation (TS) to distinguish iron overload from inflammatory/metabolic causes—if TS ≥45%, proceed to HFE genetic testing; if TS is normal, investigate secondary causes including metabolic syndrome, alcohol use, and chronic inflammation. 1

Initial Diagnostic Algorithm

Step 1: Measure Transferrin Saturation

The critical first step is obtaining a fasting transferrin saturation alongside the ferritin level 1. This single test determines your entire diagnostic pathway:

• TS ≥45% with elevated ferritin: Proceed directly to HFE mutation analysis (C282Y and H63D testing) 1
• TS <45% with elevated ferritin: Iron overload is unlikely; investigate secondary causes 1, 2

Important caveat: In the general population, iron overload is NOT the most common cause of elevated ferritin 1. Ferritin is an acute-phase reactant that rises with inflammation, making it a poor standalone marker.

Step 2: If TS is Normal (<45%)—Evaluate Secondary Causes

When TS is normal, elevated ferritin typically reflects one of these conditions (in order of frequency):

1. Metabolic syndrome/NAFLD (most common)

   • Check: BMI, blood pressure, fasting glucose, lipid panel, hemoglobin A1c
   • Look for: insulin resistance, hypertriglyceridemia, central obesity 2
   • Note: Ferritin can reach >1000 µg/L in NAFLD without iron overload 3

2. Chronic alcohol consumption

   • Quantify intake carefully
   • Check: AST/ALT ratio (typically >2 in alcoholic liver disease) 1

3. Inflammatory conditions

   • Check: CRP, ESR
   • Screen for: chronic infections, autoimmune diseases, malignancy 1, 4

4. Liver disease (though you specified normal liver enzymes)

   • Chronic hepatitis B or C
   • Consider if other risk factors present 1

Critical point from NAFLD guidelines: Elevated ferritin in NAFLD patients should NOT automatically prompt iron overload evaluation unless TS is also elevated 2. This prevents unnecessary testing and patient anxiety.

Step 3: If TS ≥45%—Genetic Testing and Further Workup

When both ferritin and TS are elevated, proceed with:

HFE genotype testing for C282Y and H63D mutations 1:

• C282Y homozygotes: Confirmed hereditary hemochromatosis

  • If ferritin <1000 µg/L, age <40, no hepatomegaly: Start phlebotomy without liver biopsy 1
  • If ferritin >1000 µg/L: Consider liver biopsy to assess for cirrhosis (80% risk if also elevated ALT and platelets <200) 1

• C282Y/H63D compound heterozygotes: May have mild iron overload

  • Investigate other cofactors (alcohol, viral hepatitis, NAFLD) 1
  • Management guided by phenotype, not genotype alone 5

• H63D homozygotes or single heterozygotes: Rarely cause significant iron overload

  • Reassure patient; yearly monitoring if ferritin elevated 1

• No HFE mutations with elevated TS and ferritin: Consider non-HFE hemochromatosis

  • Obtain liver MRI to quantify hepatic iron concentration 5, 6, 7
  • If MRI confirms iron overload, refer to specialized center for rare genetic testing (TFR2, SLC40A1, HAMP, HJV) 4, 5

Key Thresholds and Risk Stratification

Ferritin <1000 µg/L: Accurately predicts absence of cirrhosis in hemochromatosis (97% negative predictive value) 1

Ferritin >1000 µg/L + elevated ALT + platelets <200: 80% probability of cirrhosis in C282Y homozygotes—requires liver biopsy 1

Common Pitfalls to Avoid

1. Don't order HFE testing without checking TS first 1, 4. This leads to false-positive genetic results in patients with secondary hyperferritinemia.

2. Don't assume elevated ferritin = iron overload 1. In >90% of outpatients with hyperferritinemia, the cause is metabolic syndrome, inflammation, alcohol, or liver disease—not iron overload 4.

3. Don't ignore autoantibodies in NAFLD patients: ANA >1:160 or ASMA >1:40 occur in 21% of NAFLD patients without autoimmune hepatitis 2. Only pursue autoimmune workup if hypergammaglobulinemia is also present.

4. Don't perform liver biopsy for diagnosis in suspected hemochromatosis 1, 4. Biopsy is only indicated to assess for cirrhosis in high-risk patients (ferritin >1000 µg/L, age >40, hepatomegaly, elevated liver enzymes).

When to Use MRI

Liver MRI for iron quantification is indicated when 5, 6, 7:

• Elevated TS and ferritin with negative or inconclusive HFE testing
• Suspected non-HFE hemochromatosis
• Need to confirm iron overload before starting phlebotomy in unclear cases
• Monitoring response to iron chelation therapy

MRI T2* or R2 relaxometry is the non-invasive gold standard for measuring hepatic iron concentration, replacing liver biopsy in most scenarios 5, 7.

Family Screening Considerations

If hemochromatosis is confirmed (C282Y homozygote), all first-degree relatives require screening with both TS, ferritin, AND HFE genotyping simultaneously 1, 5. This single-visit approach is cost-effective and prevents delayed diagnosis in asymptomatic relatives who may already have iron accumulation.